• Contact Us

Big Pharma Give Much Needed Brexit Boost to Pharmaceuticals Industry Through Commitment to UK Investment

on Tuesday, 30 August 2016.

AstraZeneca has announced its commitment to spending £330million on a new research and development centre in Cambridge

This was after stating that it is 'hard to find a better place in the world' to do science. The announcement follows that of GlaxoSmithKline regarding plans to invest £275million in its UK manufacturing plants.

The announcement by these big pharma companies of their commitment to remain in the UK comes at a time when reassurance is much needed as to the future of pharma in the UK after the Brexit vote.


For more information, please contact a member of our Pharmaceutical Law and Life Sciences team, or complete the form below.

 

Get in Touch

First name(*)
Please enter your first name.

Last name(*)
Invalid Input

Email address(*)
Please enter a valid email address

Telephone
Please insert your telephone number.

How would you like us to contact you?

Invalid Input

How can we help you?(*)
Please limit text to alphanumeric and the following special characters: £.%,'"?!£$%^&*()_-=+:;@#`

See our privacy page to find out how we use and protect your data.

Invalid Input